BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1787550)

  • 21. Baseline characteristics of patients predicting suitability for rapid naltrexone induction.
    Mogali S; Khan NA; Drill ES; Pavlicova M; Sullivan MA; Nunes E; Bisaga A
    Am J Addict; 2015 Apr; 24(3):258-264. PubMed ID: 25907815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers.
    Vining E; Kosten TR; Kleber HD
    Br J Addict; 1988 May; 83(5):567-75. PubMed ID: 3382815
    [No Abstract]   [Full Text] [Related]  

  • 23. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
    Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
    Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of naltrexone-accelerated detoxification in opioid dependence.
    Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G
    Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone shortened opioid detoxification with buprenorphine.
    Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
    Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary care-based ambulatory opioid detoxification: the results of a clinical trial.
    O'Connor PG; Waugh ME; Carroll KM; Rounsaville BJ; Diagkogiannis IA; Schottenfeld RS
    J Gen Intern Med; 1995 May; 10(5):255-60. PubMed ID: 7616334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique.
    Brewer C; Rezae H; Bailey C
    Br J Psychiatry; 1988 Sep; 153():340-3. PubMed ID: 3250670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling.
    Rabinowitz J; Cohen H; Kotler M
    Psychiatr Serv; 1998 Jun; 49(6):831-3. PubMed ID: 9634168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure monitoring at home for rapid opioid withdrawal with clonidine and naltrexone.
    Brewer C
    Lancet; 1987 Mar; 1(8533):621. PubMed ID: 2881149
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A; Papiasvilli A; Joseph H
    J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of clonidine suppression of opiate withdrawal reactions: a multidisciplinary approach.
    Cuthill JD; Beroniade V; Salvatori VA; ViguiƩ F
    Can J Psychiatry; 1990 Jun; 35(5):377-82. PubMed ID: 2372746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
    Cheskin LJ; Fudala PJ; Johnson RE
    Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts.
    Navaratnam V; Jamaludin A; Raman N; Mohamed M; Mansor SM
    Drug Alcohol Depend; 1994 Feb; 34(3):231-6. PubMed ID: 8033761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid opiate detoxification.
    Bartter T; Gooberman LL
    Am J Drug Alcohol Abuse; 1996 Nov; 22(4):489-95. PubMed ID: 8911587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.